These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 15500134

  • 1. [RAS blockade].
    Jin C, Ito S.
    Nihon Rinsho; 2004 Oct; 62(10):1880-4. PubMed ID: 15500134
    [Abstract] [Full Text] [Related]

  • 2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
    Weir MR.
    Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
    [Abstract] [Full Text] [Related]

  • 3. Effect of renin-angiotensin-aldosterone system triple blockade on non-diabetic renal disease: addition of an aldosterone blocker, spironolactone, to combination treatment with an angiotensin-converting enzyme inhibitor and angiotensin II receptor blocker.
    Furumatsu Y, Nagasawa Y, Tomida K, Mikami S, Kaneko T, Okada N, Tsubakihara Y, Imai E, Shoji T.
    Hypertens Res; 2008 Jan; 31(1):59-67. PubMed ID: 18360019
    [Abstract] [Full Text] [Related]

  • 4. Renin angiotensin system blockade and cardiovascular outcomes in patients with chronic kidney disease and proteinuria: a meta-analysis.
    Balamuthusamy S, Srinivasan L, Verma M, Adigopula S, Jalandhara N, Hathiwala S, Smith E.
    Am Heart J; 2008 May; 155(5):791-805. PubMed ID: 18440325
    [Abstract] [Full Text] [Related]

  • 5. Dual blockade of the renin-angiotensin system in the progression of renal disease: the need for more clinical trials.
    Fernandez-Juárez G, Barrio V, de Vinuesa SG, Goicoechea M, Praga M, Luño J.
    J Am Soc Nephrol; 2006 Dec; 17(12 Suppl 3):S250-4. PubMed ID: 17130270
    [Abstract] [Full Text] [Related]

  • 6. Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
    Soliman N.
    Nephrol Dial Transplant; 2009 Sep; 24(9):2951; author reply 2951-2. PubMed ID: 19541663
    [No Abstract] [Full Text] [Related]

  • 7. Antiproteinuric response to dual blockade of the renin-angiotensin system in primary glomerulonephritis: meta-analysis and metaregression.
    Catapano F, Chiodini P, De Nicola L, Minutolo R, Zamboli P, Gallo C, Conte G.
    Am J Kidney Dis; 2008 Sep; 52(3):475-85. PubMed ID: 18468748
    [Abstract] [Full Text] [Related]

  • 8. [Blockade of the renin-angiotensin system by a combination of ACE inhibitors and AT1 receptor antagonists].
    Azizi M.
    Rev Prat; 2004 Jun 15; 54(11):1167-74. PubMed ID: 15496022
    [Abstract] [Full Text] [Related]

  • 9. Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.
    Freiberger V, Amann K, Heemann U, Frank H.
    Transpl Int; 2009 Nov 15; 22(11):1110-3. PubMed ID: 19497068
    [Abstract] [Full Text] [Related]

  • 10. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C, Corna D, Gagliardini E, Conti S, Arnaboldi L, Benigni A, Remuzzi G.
    Am J Physiol Renal Physiol; 2010 Nov 15; 299(5):F1203-11. PubMed ID: 20719975
    [Abstract] [Full Text] [Related]

  • 11. [Debate concerning the optimal blockage of the renin-angiotensin system].
    Choukroun G.
    Nephrol Ther; 2010 Jan 15; 6 Spec No 1():H1-9. PubMed ID: 20129454
    [No Abstract] [Full Text] [Related]

  • 12. Angiotensin II type 1 receptor blockade: high hopes sent back to reality?
    Grothusen A, Divchev D, Luchtefeld M, Schieffer B.
    Minerva Cardioangiol; 2009 Dec 15; 57(6):773-85. PubMed ID: 19942847
    [Abstract] [Full Text] [Related]

  • 13. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L, Kocks MJ, Laverman GD, Navis G.
    Minerva Med; 2004 Oct 15; 95(5):395-409. PubMed ID: 15467515
    [Abstract] [Full Text] [Related]

  • 14. Angiotensin receptor blockers in chronic renal disease: the promise of a bright clinical future.
    Mackenzie HS, Ziai F, Omer SA, Nadim MK, Taal MW.
    J Am Soc Nephrol; 1999 Apr 15; 10 Suppl 12():S283-6. PubMed ID: 10201884
    [Abstract] [Full Text] [Related]

  • 15. Dual renin-angiotensin-aldosterone system inhibition: boon or bust?
    Hirsch S.
    Int J Clin Pract; 2010 Sep 15; 64(10):1337-40. PubMed ID: 20716140
    [No Abstract] [Full Text] [Related]

  • 16. New therapeutic strategies with combined renin-angiotensin system inhibitors for pediatric nephropathy.
    Zaffanello M, Franchini M, Fanos V.
    Pharmacotherapy; 2008 Jan 15; 28(1):125-30. PubMed ID: 18154482
    [Abstract] [Full Text] [Related]

  • 17. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
    Wade VL, Gleason BL.
    Ann Pharmacother; 2004 Jan 15; 38(7-8):1278-82. PubMed ID: 15187210
    [Abstract] [Full Text] [Related]

  • 18. [Renin-angiotensin system as a potential target for the treatment with heart failure: ACE inhibitors, angiotensin-II receptor blockers and aldosterone antagonists].
    Sanada S, Kitakaze M.
    Nihon Rinsho; 2003 May 15; 61(5):821-6. PubMed ID: 12755009
    [Abstract] [Full Text] [Related]

  • 19. Are two better than one? Angiotensin-converting enzyme inhibitors plus angiotensin receptor blockers for reducing blood pressure and proteinuria in kidney disease.
    Linas SL.
    Clin J Am Soc Nephrol; 2008 Jan 15; 3 Suppl 1(Suppl 1):S17-23. PubMed ID: 18178792
    [Abstract] [Full Text] [Related]

  • 20. Renin-angiotensin system dual blockade using angiotensin receptor plus aliskiren decreases severe proteinuria in kidney transplant recipients.
    López V, Martin M, Cobelo C, Aranda P, Cabello M, Sola E, Gutierrez C, Burgos D, Martínez D, Hernandez D.
    Transplant Proc; 2010 Oct 15; 42(8):2883-5. PubMed ID: 20970559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.